AI assistant
Dolby Laboratories, Inc. — Director's Dealing 2023
Dec 14, 2023
30828_dirs_2023-12-14_f6c2dd7e-1a65-4658-9ffd-24b21fb49a2d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Dolby Laboratories, Inc. (DLB)
CIK: 0001308547
Period of Report: 2023-12-12
Reporting Person: YEAMAN KEVIN J (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-12 | Class A Common Stock | M | 18060 | $42.98 | Acquired | 69939 | Indirect |
| 2023-12-12 | Class A Common Stock | S | 18060 | $89.1714 | Disposed | 51879 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-12-12 | Employee Stock Option (Right to Buy) | $42.98 | M | 18060 | Disposed | 2024-12-15 | Class A Common Stock (18060) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock | 119557 | Direct |
Footnotes
F1: The shares were sold in multiple transactions at prices ranging from $88.96 to $89.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2: Shares held following the reported transactions include 119,557 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F3: This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.